Related Experiment Video

Updated: Dec 29, 2025

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.4K

Siva 1 Inhibits Cervical Cancer Progression and Its Clinical Prognosis Significance

Ting Liu1, Yifei Ma2, Zhiling Wang1

  • 1Department of Gynecology, Qilu Hospital of Shandong University, Jinan, Shandong 250012, People's Republic of China.

Cancer Management and Research
|February 6, 2020
PubMed
Abstract

Insights

Reduced Siva 1 expression correlates with cervical cancer progression and poorer survival. Restoring Siva 1 (Suppressor of IKK and VDAC interacting protein 1) inhibits tumor cell proliferation, migration, and invasion, suggesting its potential as a prognostic marker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cervical cancer is a leading female malignancy with unclear etiology.
  • Loss of Siva 1 (Suppressor of IKK and VDAC interacting protein 1) expression is linked to various tumors.
  • The role of Siva 1 in cervical cancer progression requires further elucidation.

Purpose of the Study:

  • To investigate the functional role of Siva 1 in cervical cancer.
  • To determine if Siva 1 expression serves as a prognostic indicator.

Main Methods:

  • Immunohistochemistry used to detect Siva 1 expression in 87 cervical cancer, 34 CIN, and 20 normal samples.
  • Kaplan-Meier analysis assessed the correlation between Siva 1 expression and overall survival.
  • Functional assays (CCK8, flow cytometry, wound-healing, Transwell) evaluated Siva 1's impact on cell proliferation, apoptosis, migration, and invasion after ectopic expression.

Main Results:

  • Siva 1 expression was significantly decreased in cervical cancer tissues compared to CIN and normal tissues.
  • Lower Siva 1 immunoreactivity correlated with poor tumor differentiation and decreased overall survival.
  • Elevated Siva 1 expression promoted apoptosis and suppressed proliferation, migration, and invasion in cervical cancer cells.

Conclusions:

  • Siva 1 plays a critical role in regulating cervical cancer progression.
  • Siva 1 may serve as a valuable prognostic biomarker for cervical cancer.
Keywords:
Siva 1apoptosiscervical cancerprognosisproliferation

More Related Videos

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer04:20

Author Spotlight: Exploring the Role of FAM83A in Cervical Cancer

Published on: February 9, 2024

1.3K
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment07:29

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

12.1K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K